Mortality trends for primary liver cancer in Puglia, Italy

European Journal of Cancer Prevention

Volumn 19, Issue 6, 2010, Pages 417-423

  Coviello, Enzo ^a   Caputi, Giovanni ^a   Martinelli, Domenico ^b   Germinario, Cinzia A ^c   Prato, Rosa ^c  

^a ASL BAT   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF FOGGIA   (Italy)

Author keywords

age period cohort models; Italy; mortality rates; primary liver cancer; trends

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; ITALY; LIVER CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; TREND STUDY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CITIES; COHORT STUDIES; HUMANS; ITALY; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; RISK FACTORS;

EID: 77958189208     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32833ad36e     Document Type: Article

References (30)

1. Ansaldi F, Bruzzone B, Salmaso S, Rota MC, Durando P, Gasparini R, Icardi G (2005). Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy. J Med Virol 76:327-332.
2. But DYK, Lai CL, Yuen MF (2008). Natural history of hepatitis-related hepatocellular carcinoma. World J Gastroenterol 14:1652-1656.
3. Carstensen B (2007). Age-period-cohort models for the Lexis diagram. Stat Med 26:3018-3045.
4. Carstensen B (2009a). Epi: a package for epidemiological analysis in R. [http:// cran.r-project.org/]. [Accessed 12 June 2009]
5. Carstensen B (2009b). Statistical analysis in the Lexis diagram: age-period-cohort models; 2009. [http://staff.pubhealth.ku.dk/~bxc/APC/MPIDR- 2009/pracs.pdf]. [Accessed 12 June 2009]
6. Chen SL, Morgan TR (2006). The natural history of hepatitis C virus (HCV) infection. Int J Med Sci 3:47-52.
7. Clayton D, Schifflers E (1987a). Models for temporal variation in cancer rates. I: age-period and age-cohort models. Stat Med 6:449-467.
8. Clayton D, Schifflers E (1987b). Models for temporal variation in cancer rates. II: age-period and age-cohort models. Stat Med 6:469-481.
9. Dal Maso L, Lise M, Zambon P, Crocetti E, Serraino D, Ricceri F (2008). Incidence of primary liver cancer in Italy between 1988 and 2002: an age- period-cohort analysis. Eur J Cancer 44:285-292.
10. Franceschi S, Montella M, Polesel J, La Vecchia C, Crispo A, Dal Maso L, et al. (2006). Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy. Cancer Epidemiol Biomarkers Prev 15:683-689.
11. Gruppo di lavoro sulla mortalitÁ dell'Osservatorio Epidemiologico della Regione Puglia. Atlas of the causes of death of the Puglia Region Years 2000- 2005. [Italian.] ; 2008. [http://www.oerpuglia.org/Atlante.asp]. [Accessed 12 June 2009]
12. Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, et al. (1997). Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 26:1006-1011.
13. Holford TR (1991). Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Publ Health 12:425-457.
14. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, et al. (1990). Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12:671-675.
15. La Vecchia C, Lucchini F, Franceschi S, Negri E, Levi F (2000). Trends in mortality from primary liver cancer in Europe. Eur J Cancer 36:909-915.
16. Lepage C, Remontet L, Launoy G, TrÕtarre B, Grosclaude P, Colonna M, et al. (2008). Trends in incidence of digestive cancers in France. Eur J Cancer Prev 17:13-17.
17. Malvezzi M, Bosetti C, Negri E, La Vecchia C, Decarli A (2008). Cancer mortality in Italy, 1970-2002. Tumori 94:640-657.
18. Minola E, Prati D, Suter F, Maggiolo F, Caprioli F, Sonzogni A, et al. (2002). Age at infection affects the long-term outcome of transfusion-associated chronic hepatitis C. Blood 99:4588-4591.
19. Montalto G, Cervello M, Giannitrapani L, Dantona F, Terranova A, Castagnetta LA (2002). Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann NY Acad Sci 963:13-20.
20. Montella M, Crispo A, Serraino D, Rezza G, Franceschi S (2003). Is the spread of HCV in Southern Italy attributable to iatrogenic transmission through unsterile injections? Eur J Cancer Prev 12:85-86.
21. Parkin DM (2006). The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118:3030-3044.
22. Poynard T, Bedossa P, Opolon P (1997). Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 349:825-832.
23. Raza SA, Clifford GM, Franceschi S (2007). Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br J Cancer 96:1127-1134.
24. Rutherford MJ, Lambert PC, Thompson JR (in press). Age-period-cohort modelling. Stata J.
25. Sagnelli E, Stroffolini T, Mele A, Almasio P, Coppola N, Ferrigno L, et al. (2005). The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9997 cases. J Med Virol 75: 522-527.
26. Stanta G, Croce LS, Bonin S, Tisminetzky SG, Baralle FE, Tiribelli C (2000). Cohort effect of HCV infection in liver cirrhosis assessed by a 25 year study. J Clin Virol 17:51-56.
27. Stroffolini T, Andreone P, Andriulli A, Ascione A, Craxi A, Chiaramonte M, et al. (1998). Characteristics of hepatocellular carcinoma in Italy. J Hepatol 29:944-952.
28. Stroffolini T (2005). Etiological factor of hepatocellular carcinoma in Italy. Minerva Gastroenterol Dietol 51:1-5.
29. Tango T, Kurashina S (1987). Age, period and cohort analysis of trends in mortality from major diseases in Japan, 1955-1979: peculiarity of the cohort born in the early Showa era. Stat Med 6:709-726.
30. Tong MJ, el-Farra NS, Reikes AR, Co RL (1995). Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332:1463-1466.